USPTO 2015–2025 USPTO PatentsView US Corporation

New Pelvic Pain Technologies Inc.

USPTO PatentsView assignee record - 6 granted patents across 0 technology areas, recorded in grant years 2019–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, New ranks #41,927 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 0 technology areas.

#41,927
of 49,997 US assignees by volume
0th percentile
by Innovation Score (7.3/100)
1.0
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R41927 · US Corporation #41,927 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-RICH

  • GRANTS-MICRO 6 grants
  • LOWER-Q #41,927/49,997
  • PHOTO-FINISH New Asia
  • CPC-UNK CPC blank
  • INNOV-LOW 7.3/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: New Asia Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How New’s 7.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around New

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows New's Innovation Score is 7.3/100 (0th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for New?

Each dot is one of New’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). New’s own 1.0 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

New vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 5.96.06.066.06.06.1 0510152025 Granted patents (volume) Avg claims / patent New Asia Co., Ltd. - 6, 16.67New AsiaNew H3C Information Technologies Co., Ltd. - 6, 14.5New H3C Informati…New Hampshire Ball Bearing, Inc. - 6, 15.33New Hampshire Bal…New Mexico Tech Research Foundation - 6, 15.5New Mexico Tech R…New Vision Display, Inc. - 6, 11.83New Vision DisplayNewBio Therapeutics, Inc. - 6, 20.83Newbio Therapeuti…NewPhotonics Ltd. - 6, 16.67NewphotonicsNewronika S.p.A. - 6, 20.17Newronika S p ANew Pelvic Pain Technologies Inc. - 6, 1New Pelvic Pain
New vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where New's grants concentrate

New Pelvic Pain Technologies Inc. is a focused PatentsView assignee: 0 CPC subclasses . By volume, New sits between New Asia Co., Ltd. and Newronika S.p.A..

Who files at New's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows New holds 6 patents at rank #41,979, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near New

By rank, the assignees closest to #41,979 in granted patent volume.

New's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

7 0th percentile higher than 0% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2 201920202021 2
USPTO utility patent grants by year · 2019–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
New Pelvic Pain Technologies Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 2 33.3%
2020 2 33.3%
2021 2 33.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

New Pelvic Pain Technologies Inc.'s patent record in context - here's where to go next.

  • Ranked #41,927 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare New Pelvic Pain Technologies Inc. against New Asia Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 7.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.